Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 9 Neoplasms 7 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Prostatic Neoplasms 4 Melanoma 4 Breast Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Head and Neck Neoplasms 3 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Anxiety Disorders 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rare Malignant Neoplasm 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Nephrotic Syndrome 1 Neoplasms, Plasma Cell 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00596154 2024-04-01

PCNSL

Memorial Sloan Kettering Cancer Center

Phase 2 Completed

33 enrolled 9 charts

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡